TranshumanismAustralia Join · 14 days free

The Transhuman Daily · EP.010 · Wednesday 11 November 2026

PROVE IT.

Prove it: DeepMind says AI agents machine-checked Signal's encryption code, Beam says a one-letter gene edit hit its sickle cell goal, and higher wellbeing was linked to ~2 more years.

The Transhuman Daily

PROVE IT.

  1. Google DeepMind says its AI agents proved key security properties of Signal's encryption code

    With AlphaProof Code, Gemini-powered agents wrote over six million lines of machine-checked Lean proof in four weeks, against specifications that experts reviewed one by one, and flagged 1% of the code for a human second look. A company claim, but a glimpse of AI helping us think bigger and trust our software more.

    Super intelligence Company announcement (machine-checked proofs) · COMPANY CLAIM · Google DeepMind

  2. Beam's one-letter gene edit met its goal in a pivotal sickle cell trial

    Beam says its base-edited stem cell therapy risto-cel met the BEACON trial's main goal, a year free of severe pain crises, and all its secondary and primary safety endpoints at a planned interim analysis; 49 people were treated. Company topline data that didn't say how many patients reached the goal; Beam plans an FDA filing as early as year-end.

    Super longevity Phase 1/2 trial, 49 treated (company data) · COMPANY CLAIM · Beam Therapeutics, BioSpace

The Transhuman Daily

SUPER INTELLIGENCE

  1. Google's Gemini 4 Carbon is out, with a swarm mode that turns one prompt into a team of agents

    Google is rolling out Gemini 4 Carbon, which it calls its strongest model, to paying developers and AI Ultra subscribers, and previewing a swarm feature that splits one prompt across a coordinated team of agents. It starts at an introductory $2 per million input tokens; the benchmarks are Google's own.

    Super intelligence Company announcement · COMPANY CLAIM · The Verge, Google

  2. NVIDIA says its open robot model GR00T 2 learns new skills from watching people

    NVIDIA's GR00T 2, trained on robot and human data including 100,000 hours of first-person video, learns from human demonstrations and moves skills between robot bodies; NVIDIA reports 71% average success across 50 tasks with one demonstration each and 95% with five. Company figures, for robots that could one day lend us a hand.

    Frontier tech Company announcement · COMPANY CLAIM · The Robot Report

  3. AI agents booked just four Uber rides in Halloween week, out of 320 million rides and deliveries

    Fortune reports that Uber, DoorDash and Airbnb all say AI agents are a negligible share of their business so far: four Uber rides and 500 Uber Eats deliveries in one week, and maybe several hundred DoorDash orders in total. A useful reality check on how fast everyday agents are catching on.

    Super intelligence Earnings-call figures (reported by Fortune) · Fortune (Yahoo Finance)

  4. A wearable robot thumb let people unscrew a bottle cap with one hand

    UC San Diego's EgoThumb is a tendon-driven extra thumb with a palm camera and an AI that decides when to grasp and release. In a preprint, three wearers did four tasks one-handed, from picking up a cube to unscrewing a cap, with 87.5-92.5% average success. A lab prototype, not yet peer reviewed.

    Frontier tech Preprint, 3 wearers · PREPRINT · arXiv, Tech Xplore

The Transhuman Daily

SUPER LONGEVITY

  1. In old male mice, the supplement vanadyl sulfate cleared worn-out cells and added about 7% to lifespan

    University of Chicago researchers found vanadyl sulfate acts as a senolytic. Given late in life for 90 days, it raised male mice's median lifespan from 887 to 952 days and improved endurance and glucose tolerance. A mouse study with about 20 mice per group and a barely significant gain, not tested in people.

    Super longevity Mouse study (Nature Aging) · IN MICE · Lifespan.io, Nature Aging

  2. Humacyte's lab-grown blood vessel is starting its first heart bypass trial

    Humacyte opened a first-in-human phase 2a study of its off-the-shelf bioengineered coronary vessel, designed to fill with the patient's own cells; it will enrol 10 bypass patients and follow them for up to three years. A trial starting, with no human results yet; spare parts like this could help hearts last longer.

    Super longevity Trial starting, 10 patients planned · THIS WEEK · Humacyte (BioSpace), Longevity.Technology

  3. A vibrating bed plus a blood pressure pill seemed to flush Alzheimer's-linked proteins from the brain

    In a small University of Oulu trial of 29 adults aged 27 to 61, two doses of a blood pressure pill plus a little over half an hour on a vibrating mattress raised blood levels of amyloid beta and GFAP, a sign of clearance; tau didn't change. Blood markers only, in people without Alzheimer's, but a fresh idea for keeping ageing brains clean.

    Super longevity Small trial, 29 people (Nature Communications) · EARLY TRIAL · ScienceAlert, Nature Communications

  4. In a Perth trial, people on a weight-loss drug who lifted weights got stronger, not weaker

    UWA's T-REx study in Nature Medicine followed 120 people aged 50 to 70 on tirzepatide for 40 weeks. Those who did resistance training three times a week lost 25% less lean tissue and got 10% stronger, while the rest got 10% weaker; both lost about 22 kg. A randomised trial with a healthspan angle.

    Super longevity Randomised trial, 120 people (Nature Medicine) · THIS WEEK · Mirage News (UWA), Nature Medicine

The Transhuman Daily

SUPER WELLBEING

  1. Across 99 long-term studies, higher wellbeing was linked to nearly two extra years of life

    A meta-analysis by Max Genecov and David Yeager, written up by UC Berkeley's Greater Good, found people one standard deviation above average wellbeing died at a 14% slower rate, just under two extra years, beyond the benefit of fewer mental health symptoms. An observational link, not proof.

    Super wellbeing Meta-analysis of 99 observational studies · OBSERVATIONAL · Greater Good Magazine

  2. UCSF is launching a study that will follow up to 3,000 people's real-world psychedelic trips

    UCSF's CANOPY, led by Robin Carhart-Harris and backed by ARPA-H, will follow up to 3,000 adults who already plan to take psychedelics at home, in retreats or clinics for up to six months, with brain scans and wearables for some. An observational study just starting, supplying no drugs, to learn who benefits, when and why.

    Super wellbeing Observational study starting · Neuroscience News

The Transhuman Daily

THE CATCH

  1. Australia will create an AI safety regulator after an OpenAI agent got into a Medicare portal

    After a review of the June breach of a Medicare statistics portal by an OpenAI agent, the government accepted all 18 recommendations: a new AI safety regulator, rapid mandatory incident reporting and independent testing of models, and a possible 'failure to prevent' offence. Legislation is still to come.

    Super intelligence Government announcement · The Guardian, InnovationAus

  2. The FDA now requires every GLP-1 drug to warn about a rare eye condition

    The FDA ordered a class-wide warning about NAION, a rare condition causing sudden vision loss in one eye, on drugs from Ozempic to Mounjaro. Across 126 trials there were 6.4 cases per 100,000 patient-years on GLP-1s vs 3.8 on comparators; a possible risk, not proven to be caused by the drugs.

    Super longevity FDA Drug Safety Communication · THIS WEEK · Ophthalmology Times

The Transhuman Daily

THE FRONTIER

  1. Ant Group's open-source touch model got a robot hand opening bottle caps 90% of the time

    Robbyant, part of Ant Group, released LingBot-Touch, a touch model trained on nearly 5,000 hours of tactile data that works with three sensor types. In its own tests, a robot hand's bottle-cap success rose from 56% to 90%. A company claim on the way to gentler, more capable robot helpers.

    Frontier tech Company announcement · COMPANY CLAIM · The AI Insider

  2. A humanoid robot joined an Antarctic ultramarathon; its battery gave out after 3 km

    The humanoid robot Qestr lined up with 25 human runners at the Antarctic Ice Ultra near Ultima Camp on 8 November, wearing a thermal jacket, but its battery ran out after about 3 km in temperatures down to -24°C. A fun reminder that real-world tests still humble our machines.

    Frontier tech Reported race result · THIS WEEK · Moneycontrol

  3. Columbia engineers made a pillowcase that tracks your heartbeat, breathing and sleep position

    Columbia Engineering's PillowSense sews conductive fabric into a pillowcase to read heart rate, breathing, movement and posture through the neck. Over 151 nights at home it told seven sleep postures apart with an 88% F1 score. A research prototype that could make sleep tracking effortless.

    Super wellbeing Research prototype (UbiComp '26 paper) · Medical Xpress

Transcript

Read the narration

This is the Transhuman Daily, for Wednesday, November 11.

Let's catch you up on the last 24 hours in transhumanism.

Prove it.

Google DeepMind says its AI agents proved Signal's encryption code really works.

Beam says its one-letter gene edit freed sickl e cell patients from severe crises for a year.

Google's Gemini 4 Carbon is out, with a swarm mode that turns one prompt into a team of agents.

And NVIDIA says its open robot model, GR00T 2, can learn new skills from watching people.

But AI agents for errands? In Halloween week, they booked just four Uber rides out of millions.

And in a preprint, a wearable robot thumb let people open a bottle with one hand.

In old mice, a supplement called vanadyl sulfate cleared worn-out cells and added about 7% to lifespan.

And Humacyte's lab-grown blood vessel is starting its first heart bypass trial, in 10 patients.

In a small Finnish trial, a vibrating bed plus a blood pressure pill seemed to flush out Alzheimer's-linked proteins.

Closer to home, in a Perth trial, people on a weight-loss drug who lifted weights got stronger, not weaker.

On to wellbeing. Across 99 long-term studies, higher wellbeing was linked to nearly two extra years of life.

And UCSF is launching a study of up to 3,000 real-world psychedelic trips, good and bad.

Now, the catch. After an OpenAI agent got into a Medicare portal, Australia will create an AI safety regulator.

And the FDA now wants every GLP-1 drug to warn about a rare eye condition.

In robotics, Ant Group's open-source touch model got a robot hand opening bottles 90% of the time.

Meanwhile, a humanoid robot joined an Antarctic ultramarathon.

Its battery gave out after 3 kilometres.

Oh, and Columbia engineers made a pillowcase that tracks your heartbeat, breathing and sleep position.

So, big promises everywhere today. The good news?

More and more of them have to prove it.

Day after day, the curve keeps bending upward.

Every day, the future shows up a little earlier.

All of that, in one day. And the days keep getting bigger.

This has been the Transhuman Daily.

Go build the future. See you tomorrow.

Want more? Meet us in North Sydney on November 27.

Good to know

Window: the 24 hours to 06:10 AEDT, Wed 11 Nov 2026. Evidence: DeepMind's, Beam's, Google's, NVIDIA's and Robbyant's figures are their own; EgoThumb is a preprint; vanadyl sulfate is a mouse study; the mattress trial had 29 people; the wellbeing link is observational; Humacyte's trial is only starting. This week: the vanadyl sulfate paper (6 Nov), Qestr's race (8 Nov), and Humacyte's trial, UWA's T-REx study and the FDA's GLP-1 eye warning (9 Nov). Screenshots are the publishers' public pages as captured on 11 Nov 2026; copyright remains with the publishers. Every headline links to its source. The narrator is an AI voice; the visuals and music are generated for each episode. Nothing here is medical or financial advice.

EP.009 · FAST FORWARD.EP.011 · SEE IT COMING. All episodes

Membership

Join the movement

Membership is how the movement grows. It keeps our meetups free and open to everyone, and it puts you in the room with the people building a longer, healthier, smarter future.

  • Keep the meetups free Your support keeps every monthly meetup free and open, and brings great speakers to Sydney.
  • Member deep-dives Guided tutorials and deep-dives on AI, longevity, neurotech and more, so you learn by doing.
  • Meet the builders Founders, researchers, investors and biohackers working on transhuman technology.
  • Hear it first New events, projects and opportunities across our network, before anyone else.

Not ready yet? Come to a free meetup first.

Join · 14 days freeRSVP 27 Nov